A Neutrophil/lymphocyte Ratio As a Significant Predictor for Patients with Low-risk and Early-stage Extranodal NK-T-cell Lymphoma

Overview

Journal Indian J Hematol Blood Transfus

Specialty Hematology

Date 2023 Apr 3

PMID 37006977

Authors

Wanchun Wu

Xi Chen

Na Li

Qian Luo

Liqun Zou

Affiliations

Soon will be listed here.

Abstract

Purpose: The neutrophil/lymphocyte ratio (NLR) is a novel prognostic marker in several malignancies, whereas its function in patients with early-stage extranodal NK-T-cell lymphoma (ENKTL) hasn't been explored. Therefore, we expolored the predictive value of NLR for early-stage ENKTL in this study.

Methods: We evaluated the prognostic value of NLR in 132 patients with early-stage ENKTL based on L-asparaginase-containing regimens. Their characteristics, treatment responses, survival outcomes, prognostic factors, and the prognostic value of NLR were analyzed.

Results: All patients were followed up for median 54 months. The optimal NLR cutoff value was 3.77 by receiver operating curve(ROC). For all patients, the complete response (CR) and the overall response rate (ORR) were 74.2% and 85.6%. Patients with NLR < 3.77 had higher CR and ORR than patients with NLR ≥ 3.77(CR, 81% vs. 53.1%; ORR, 90% vs. 71.9%). For all patients, the 3-year overall survival (OS) and progression-free survival (PFS) based on L-asparaginase-containing chemotherapy were 80.4% and 76%. Patients with NLR < 3.77 had better survival outcomes than patients with NLR ≥ 3.77(3-year OS, 86.9% vs. 60.3%, p = 0.002; 3-year PFS, 81.8% vs. 54.5%, p = 0.001). By univariate and multivariate analyses, NLR ≥ 3.77 was an independent poor prognostic factor for both OS and PFS. Additionally, NLR ≥ 3.77 was associated with poor survival outcomes in patients with low-risk International Prognostic Index (IPI) and Prognostic Index of Natural Killer lymphoma with Epstein-Barr virus (PINK-E).

Conclusion: A high NLR is a poor prognostic marker of survival in patients with early-stage ENKTL, and could be applied to risk-stratify for low-risk patients.

References

Haverkos B, Pan Z, Gru A, Freud A, Rabinovitch R, Xu-Welliver M . Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases. Curr Hematol Malig Rep. 2016; 11(6):514-527. PMC: 5199232. DOI: 10.1007/s11899-016-0355-9. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Kwong Y . Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005; 19(12):2186-94. DOI: 10.1038/sj.leu.2403955. View

Sabattini E, Bacci F, Sagramoso C, Pileri S . WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010; 102(3):83-7. View

Cheson B, Fisher R, Barrington S, Cavalli F, Schwartz L, Zucca E . Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014; 32(27):3059-68. PMC: 4979083. DOI: 10.1200/JCO.2013.54.8800. View

Fox C, Civallero M, Ko Y, Manni M, Skrypets T, Pileri S . Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. Lancet Haematol. 2020; 7(4):e284-e294. DOI: 10.1016/S2352-3026(19)30283-2. View

Chen M, Chen P, Kuan F, Chen W . The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2018; 26(1):190-199. DOI: 10.1245/s10434-018-6944-1. View

Lee J, Suh C, Park Y, Ko Y, Bang S, Lee J . Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2005; 24(4):612-8. DOI: 10.1200/JCO.2005.04.1384. View

Guthrie G, Charles K, Roxburgh C, Horgan P, McMillan D, Clarke S . The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013; 88(1):218-30. DOI: 10.1016/j.critrevonc.2013.03.010. View

10.

Farkas T, Muller J, Erdelyi D, Csoka M, Kovacs G . Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia. Pathol Oncol Res. 2017; 23(4):889-897. DOI: 10.1007/s12253-017-0192-8. View

11.

Shaul M, Fridlender Z . Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019; 16(10):601-620. DOI: 10.1038/s41571-019-0222-4. View

12.

Kim S, Yoon D, Jaccard A, Chng W, Lim S, Hong H . A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016; 17(3):389-400. DOI: 10.1016/S1470-2045(15)00533-1. View

13.

Stefaniuk P, Szymczyk A, Podhorecka M . The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review. Cancer Manag Res. 2020; 12:2961-2977. PMC: 7196794. DOI: 10.2147/CMAR.S245928. View

14.

Cheung M, Chan J, Lau W, Ngan R, Foo W . Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002; 54(1):182-90. DOI: 10.1016/s0360-3016(02)02916-4. View

15.

Templeton A, McNamara M, Seruga B, Vera-Badillo F, Aneja P, Ocana A . Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106(6):dju124. DOI: 10.1093/jnci/dju124. View

16.

Bi X, Xia Y, Zhang W, Sun P, Liu P, Wang Y . Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma. Ann Hematol. 2015; 94(9):1525-33. DOI: 10.1007/s00277-015-2395-y. View

17.

Yang Q, Zhang W, Yu J, Zhao S, Xu H, Wang W . Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011; 6:77. PMC: 3179701. DOI: 10.1186/1746-1596-6-77. View

18.

Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W . Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017; 111:176-181. DOI: 10.1016/j.lungcan.2017.07.024. View

19.

Hu Y, Chen M, Song Y, Liu X, Gou F, Zhang J . Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma. Am J Clin Oncol. 2019; 43(4):257-262. DOI: 10.1097/COC.0000000000000647. View

20.

Sherry A, von Eyben R, Newman N, Gutkin P, Mayer I, Horst K . Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast Cancer. Int J Radiat Oncol Biol Phys. 2019; 108(1):268-276. PMC: 7473500. DOI: 10.1016/j.ijrobp.2019.11.398. View